The Egyptian Journal of Basic and Clinical Pharmacology adheres to the highest possible ethical standards, as described, for example, by the International Committee of Medical Journal Editors (ICMJE). If an ethical problem related to a submitted or published article is referred to the Editor-in-Chief, then he will evaluate the problem as outlined by appropriate bodies such as the ICMJE and the Committee on Publication Ethics (COPE), and take appropriate steps. The following are problems in the ethics of publication that every author should be familiar with. Violations of any of the following ethical principles may incur sanctions described below.
All journals published by KenzPub are committed to publishing only original material, i.e., material that has neither been published nor is under review elsewhere. KenzPub as a participant of Crossref Similarity Check uses iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. Manuscripts that are found to have been plagiarized from a manuscript by other author(s), whether published or unpublished, will incur plagiarism sanctions.
Manuscripts that are found to have been published elsewhere, or to be under review elsewhere, will incur duplicate submission/publication sanctions. If author(s) have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they are required to cite the previous work and indicate how their submitted manuscript offers novel contributions beyond those of the previous work.
Submitted manuscripts that are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal, will incur citation manipulation sanctions.
Submitted manuscripts that are found to have either fabricated or falsified experimental results, including the manipulation of images, will incur data fabrication and falsification sanctions.
Redundant publications involve the inappropriate division of study outcomes into several articles.
In any studies, involving human subjects all work must be conducted in accordance with the Declaration of Helsinki (1964). Papers describing studies on human subjects must include a statement that their relevant institutional committee has approved the described work.
In the case of experiments involving animals, the author(s) should provide a statement assuring that the described experiments have been approved by the relevant institutional committee.
The following is a summary of our expectations from editors, reviewers, and author(s) to follow the publication ethics standards and the procedures of handling the unethical behaviors.
Editors entrust reviewers with a high level of responsibility. Reviewers are given access to privileged information (i.e. unpublished research) and their recommendations can sway the publication outcome. Unfortunately, there are rare occasions when that trust is misplaced.
Reviewer misconduct, ranging from minor issues, such as rude or unconstructive reviews, to major issues, such as the appropriation of author's ideas or data.
Minor problems are relatively easy to respond to, such as deleting rude comments and not inviting particular reviewer again if he/she supplies poor quality, late, or unconstructive review.
There may be other instances where editors receive complaints from authors about reviewer misconduct. Forward those complaints to email@example.com to be investigated and dealt with on a case-by-case basis.
When the editor or publisher is informed of misconduct or unethical behavior, they should be provided with sufficient information and evidence to help investigating such issues.
Evidence should be gathered accurately and privately, avoiding spreading any allegations beyond those who should be informed.
In case that there are documented violations, the following sanctions will be applied:
In cases where the violations of the above policies are found to be particularly egregious, the publisher reserves the right to impose additional sanctions beyond those described above.